It is interesting to note that, even in this case, the FXR pathway was involved, since various FXR downstream target genes involved in triglyceride synthesis were downregulated, whereas increased PPARα and β-oxydation activity was detected [266], and similar results were obtained in an NAFLD mouse model [267]. Here, NR1H4 is linked to metabolic dysfunction-associated steatotic liver disease.